The influence of postscreening follow‐up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trialsMengmeng Li, Hilary A. Robbins, Peter Sasieni et al.|International Journal of Cancer|2022Cited by 15
Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancerShun Lü, Yibin Wang, Yongfeng Yu et al.|Translational Lung Cancer Research|2025Cited by 2